1. Home
  2. FSHP vs ICCM Comparison

FSHP vs ICCM Comparison

Compare FSHP & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSHP
  • ICCM
  • Stock Information
  • Founded
  • FSHP 2018
  • ICCM 2006
  • Country
  • FSHP United States
  • ICCM Israel
  • Employees
  • FSHP N/A
  • ICCM N/A
  • Industry
  • FSHP
  • ICCM
  • Sector
  • FSHP
  • ICCM
  • Exchange
  • FSHP NYSE
  • ICCM Nasdaq
  • Market Cap
  • FSHP 90.7M
  • ICCM 74.7M
  • IPO Year
  • FSHP 2024
  • ICCM N/A
  • Fundamental
  • Price
  • FSHP $10.33
  • ICCM $1.24
  • Analyst Decision
  • FSHP
  • ICCM Strong Buy
  • Analyst Count
  • FSHP 0
  • ICCM 1
  • Target Price
  • FSHP N/A
  • ICCM $2.50
  • AVG Volume (30 Days)
  • FSHP 21.2K
  • ICCM 351.8K
  • Earning Date
  • FSHP 01-01-0001
  • ICCM 03-27-2025
  • Dividend Yield
  • FSHP N/A
  • ICCM N/A
  • EPS Growth
  • FSHP N/A
  • ICCM N/A
  • EPS
  • FSHP 0.17
  • ICCM N/A
  • Revenue
  • FSHP N/A
  • ICCM $3,291,000.00
  • Revenue This Year
  • FSHP N/A
  • ICCM $75.63
  • Revenue Next Year
  • FSHP N/A
  • ICCM $69.36
  • P/E Ratio
  • FSHP $62.54
  • ICCM N/A
  • Revenue Growth
  • FSHP N/A
  • ICCM 1.92
  • 52 Week Low
  • FSHP $9.99
  • ICCM $0.48
  • 52 Week High
  • FSHP $10.35
  • ICCM $1.66
  • Technical
  • Relative Strength Index (RSI)
  • FSHP N/A
  • ICCM 46.87
  • Support Level
  • FSHP N/A
  • ICCM $1.04
  • Resistance Level
  • FSHP N/A
  • ICCM $1.25
  • Average True Range (ATR)
  • FSHP 0.00
  • ICCM 0.10
  • MACD
  • FSHP 0.00
  • ICCM -0.02
  • Stochastic Oscillator
  • FSHP 0.00
  • ICCM 40.82

About FSHP FLAG SHIP ACQUISITION CORPORATION

Flag Ship Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: